Wed, February 22, 2017
Tue, February 21, 2017

Jason Wittes Initiated (TGTX) at Strong Buy and Held Target at $26 on, Feb 22nd, 2017

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. -buy-and-held-target-at-26-on-feb-22nd-2017.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Jason Wittes of Aegis Capital, Initiated "TG Therapeutics, Inc." (TGTX) at Strong Buy and Held Target at $26 on, Feb 22nd, 2017.

Jason, nor any peers, have made any analyst calls on TGTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30